Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313245134> ?p ?o ?g. }
- W4313245134 endingPage "67" @default.
- W4313245134 startingPage "67" @default.
- W4313245134 abstract "Hormone-dependent cancers, such as certain types of breast cancer are characterized by over-expression of estrogen receptors (ERs). Anticancer drug conjugates combining ER ligands with other classes of anticancer agents may not only benefit from dual action at both anti-cancer targets but also from selective delivery of cytotoxic agents to ER-positive tumor cells resulting in less toxicity and adverse effects. Moreover, they could also take advantage of overcoming resistance typical for anti-hormonal monotherapy such as tamoxifen. In this review, we discuss the design, structures and pharmacological effects of numerous series of drug conjugates containing ER ligands such as selective ER modulators (tamoxifen, 4-hydroxytamoxifen, endoxifen), selective ER degraders (ICI-164384) and ER agonists (estradiol) linked to diverse anti-cancer agents including histone-deacetylase inhibitors, DNA-alkylating agents, antimitotic agents and epidermal growth factor receptor inhibitors." @default.
- W4313245134 created "2023-01-06" @default.
- W4313245134 creator A5008709840 @default.
- W4313245134 creator A5031324853 @default.
- W4313245134 creator A5081007016 @default.
- W4313245134 date "2022-12-26" @default.
- W4313245134 modified "2023-09-26" @default.
- W4313245134 title "Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands" @default.
- W4313245134 cites W1565283549 @default.
- W4313245134 cites W1596063300 @default.
- W4313245134 cites W1600830158 @default.
- W4313245134 cites W1605167375 @default.
- W4313245134 cites W1965243176 @default.
- W4313245134 cites W1970822477 @default.
- W4313245134 cites W1972132259 @default.
- W4313245134 cites W2013809140 @default.
- W4313245134 cites W2016908879 @default.
- W4313245134 cites W2026819697 @default.
- W4313245134 cites W2028733293 @default.
- W4313245134 cites W2038491937 @default.
- W4313245134 cites W2047246104 @default.
- W4313245134 cites W2053763296 @default.
- W4313245134 cites W2059085109 @default.
- W4313245134 cites W2073100055 @default.
- W4313245134 cites W2080931196 @default.
- W4313245134 cites W2082198976 @default.
- W4313245134 cites W2087530967 @default.
- W4313245134 cites W2097479894 @default.
- W4313245134 cites W2105649494 @default.
- W4313245134 cites W2111714831 @default.
- W4313245134 cites W2114058467 @default.
- W4313245134 cites W2125850880 @default.
- W4313245134 cites W2128605357 @default.
- W4313245134 cites W2135732933 @default.
- W4313245134 cites W2149475194 @default.
- W4313245134 cites W2165866239 @default.
- W4313245134 cites W2317505970 @default.
- W4313245134 cites W2320095824 @default.
- W4313245134 cites W2320530598 @default.
- W4313245134 cites W2400526822 @default.
- W4313245134 cites W2438179605 @default.
- W4313245134 cites W2442143867 @default.
- W4313245134 cites W2488058800 @default.
- W4313245134 cites W2531607465 @default.
- W4313245134 cites W2531611585 @default.
- W4313245134 cites W2736521173 @default.
- W4313245134 cites W2750785037 @default.
- W4313245134 cites W2825082106 @default.
- W4313245134 cites W2883558292 @default.
- W4313245134 cites W2949238281 @default.
- W4313245134 cites W2951090153 @default.
- W4313245134 cites W2999417355 @default.
- W4313245134 cites W3021843737 @default.
- W4313245134 cites W3111964983 @default.
- W4313245134 cites W4221106374 @default.
- W4313245134 cites W4248107770 @default.
- W4313245134 cites W4254152438 @default.
- W4313245134 doi "https://doi.org/10.3390/pharmaceutics15010067" @default.
- W4313245134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36678697" @default.
- W4313245134 hasPublicationYear "2022" @default.
- W4313245134 type Work @default.
- W4313245134 citedByCount "1" @default.
- W4313245134 countsByYear W43132451342023 @default.
- W4313245134 crossrefType "journal-article" @default.
- W4313245134 hasAuthorship W4313245134A5008709840 @default.
- W4313245134 hasAuthorship W4313245134A5031324853 @default.
- W4313245134 hasAuthorship W4313245134A5081007016 @default.
- W4313245134 hasBestOaLocation W43132451341 @default.
- W4313245134 hasConcept C121608353 @default.
- W4313245134 hasConcept C126322002 @default.
- W4313245134 hasConcept C185592680 @default.
- W4313245134 hasConcept C2777176818 @default.
- W4313245134 hasConcept C2777944059 @default.
- W4313245134 hasConcept C2778305200 @default.
- W4313245134 hasConcept C2780035454 @default.
- W4313245134 hasConcept C502942594 @default.
- W4313245134 hasConcept C530470458 @default.
- W4313245134 hasConcept C552990157 @default.
- W4313245134 hasConcept C55493867 @default.
- W4313245134 hasConcept C64927066 @default.
- W4313245134 hasConcept C71924100 @default.
- W4313245134 hasConcept C84606932 @default.
- W4313245134 hasConcept C86803240 @default.
- W4313245134 hasConcept C98274493 @default.
- W4313245134 hasConceptScore W4313245134C121608353 @default.
- W4313245134 hasConceptScore W4313245134C126322002 @default.
- W4313245134 hasConceptScore W4313245134C185592680 @default.
- W4313245134 hasConceptScore W4313245134C2777176818 @default.
- W4313245134 hasConceptScore W4313245134C2777944059 @default.
- W4313245134 hasConceptScore W4313245134C2778305200 @default.
- W4313245134 hasConceptScore W4313245134C2780035454 @default.
- W4313245134 hasConceptScore W4313245134C502942594 @default.
- W4313245134 hasConceptScore W4313245134C530470458 @default.
- W4313245134 hasConceptScore W4313245134C552990157 @default.
- W4313245134 hasConceptScore W4313245134C55493867 @default.
- W4313245134 hasConceptScore W4313245134C64927066 @default.
- W4313245134 hasConceptScore W4313245134C71924100 @default.
- W4313245134 hasConceptScore W4313245134C84606932 @default.